Annexon ANNX
NASDAQ ANNX
$4.83 -0.01 (-0.21%)
As of: Sep 4, 2026 · 1:35 PM EDT

Annexon (ANNX) Depreciation & Amortization (CF) (2019 - 2026)

Annexon (ANNX) posted quarterly Depreciation & Amortization (CF) of $539000.0 for Q1 2026, little changed year-over-year from $537000.0 in Q1 2025, and down 0.74% quarter-over-quarter from $543000.0 in Q4 2025.

Analysis

Annexon (ANNX) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

Annexon's Depreciation & Amortization (CF) history runs 8 years deep, the most recent figure standing at $539000.0 for Q1 2026.

  • In Q1 2026, Depreciation & Amortization (CF) changed 0.37% year-over-year to $539000.0; the TTM figure through Mar 2026 stood at $2.2 million (up 0.88% YoY), while the FY2025 annual figure was $2.2 million, up 0.74% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $539000.0, down from $543000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $546000.0 in Q3 2025, with the low at $518000.0 in Q1 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $538000.0 (2023), against an average of $535823.5.
  • Peak annual rise in Depreciation & Amortization (CF) reached 4.74% in 2022, while the deepest fall reached 7.33% in 2022.
  • Annexon's Depreciation & Amortization (CF) stood at $530000.0 in 2022, then increased by 1.51% to $538000.0 in 2023, then declined by 0.19% to $537000.0 in 2024, then advanced by 1.12% to $543000.0 in 2025, then slipped by 0.74% to $539000.0 in 2026.
  • Business Quant data shows ANNX's Depreciation & Amortization (CF) at $539000.0 in Q1 2026, $543000.0 in Q4 2025, and $546000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn -
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn -
5 Revolution Medicines 44.05 Bn 44.05 Bn - -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn 40.52 Mn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn -
8 Royalty Pharma 28.44 Bn 27.60 Bn - -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn -
10 Annexon 970.85 Mn 970.85 Mn - 540,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 540,000.00
Mar 31, 2026 539,000.00
Dec 31, 2025 543,000.00
Sep 30, 2025 546,000.00
Jun 30, 2025 540,000.00
Mar 31, 2025 537,000.00
Dec 31, 2024 537,000.00
Sep 30, 2024 538,000.00
Jun 30, 2024 537,000.00
Mar 31, 2024 538,000.00
Dec 31, 2023 538,000.00
Sep 30, 2023 538,000.00
Jun 30, 2023 536,000.00
Mar 31, 2023 536,000.00
Dec 31, 2022 530,000.00
Sep 30, 2022 518,000.00
Jun 30, 2022 540,000.00
Mar 31, 2022 518,000.00
Dec 31, 2021 506,000.00
Sep 30, 2021 559,000.00